Human Anti-CD40LG (clone YMF323.6) scFv-Fc Chimera (CAT#: VS-0425-FY79)
This fusion protein targets CD40LG (CD40 ligand), a co-stimulatory molecule that plays a crucial role in immune cell interactions. It is designed to modulate immune responses and has potential applications in cancer immunotherapy and autoimmune diseases.
We specialize in custom recombinant antibody production, offering seamless execution from provided sequences to high-quality antibody deliverables, ensuring optimal yield and purity.

(Immunofluorescent staining of human cell line JURKAT shows localization to plasma membrane.)
* Image credit: Human Protein Atlas https://v21.proteinatlas.org/images/72480/2010_G3_1_selected.jpg

(Immunofluorescent staining of human cell line HEL shows localization to golgi apparatus.)
* Image credit: Human Protein Atlas https://v21.proteinatlas.org/images/72480/2069_B6_2_blue_green.jpg

(Mucosal lymphoid cells
Staining: Medium
Intensity: Strong
Quantity: <25%)
* Image credit: Human Protein Atlas https://v21.proteinatlas.org/images/72480/169295_A_9_3.jpg

(Non-germinal center cells
Staining: Medium
Intensity: Strong
Quantity: <25%
Location: Cytoplasmic/membranous)
* Image credit: Human Protein Atlas https://v21.proteinatlas.org/images/72480/169295_A_9_8.jpg

(Cell lines ordered by descending RNA expression order.)
* Image credit: Human Protein Atlas https://v21.proteinatlas.org/ENSG00000102245-CD40LG

(Cell lines ordered by descending RNA expression order.)
* Image credit: Human Protein Atlas https://v21.proteinatlas.org/ENSG00000102245-CD40LG
Specifications
- Immunogen
- The immunogen is recombinant human CD40L expressed on the surface of CHO cells.
- Host Species
- Human
- Type
- Human IgG1, scFv-Fc
- Specificity
- Human CD40LG
- Species Reactivity
- Human
- Clone
- YMF323.6
- Applications
- Flow Cytometry, ELISA, Immunohistochemistry
- Related Disease
- Idiopathic Anterior Uveitis and Cd3zeta Deficiency
Product Property
- Purity
- >95% as determined by SDS-PAGE
- Concentration
- Please refer to the vial label for the specific concentration.
- Storage
- Centrifuge briefly prior to opening vial. Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.
- Shipping
- Ice packs
Applications
- Application Notes
- Flow Cytometry: 0.1-10 μg/mL
Immunohistochemistry: 1-10 μg/mL
The optimal dilution concentration is determined by the experiment.
Target
- Alternative Names
- CD40 Ligand; TNF-Related Activation Protein; Tumor Necrosis Factor (Ligand) Superfamily Member 5; T-B Cell-Activating Molecule; CD40 Antigen Ligand; T-Cell Antigen Gp39; TNFSF5; CD40-L; CD40L; TRAP; Tumor Necrosis Factor (Ligand) Superfamily, Member 5 (Hyper-IgM Syndrome)
- Gene ID
- 959
- UniProt ID
- P29965
- Long Name
- CD40 Ligand
- Sequence Similarities
- Belongs to the tumor necrosis factor family.
- Cellular Localization
- Cell membrane; Single-pass type II membrane protein; Cell surface
- Post Translation Modifications
- The soluble form derives from the membrane form by proteolytic processing.
N-linked glycan is a mixture of high mannose and complex type.
Glycan structure does not influence binding affinity to CD40.
Not O-glycosylated.
Glycosylation at Asn240
Modification sites at PhosphoSitePlus
Glycosylation from GlyConnect CD40L_HUMAN (610)
Glycosylation from GlyGen 2 sites, 32 N-linked glycans (2 sites)
- Protein Refseq
- NP_000065.1
- Function
- Cytokine that acts as a ligand to CD40/TNFRSF5.
Costimulates T-cell proliferation and cytokine production.
Its cross-linking on T-cells generates a costimulatory signal which enhances the production of IL4 and IL10 in conjunction with the TCR/CD3 ligation and CD28 costimulation.
Induces the activation of NF-kappa-B.
Induces the activation of kinases MAPK8 and PAK2 in T-cells.
Induces tyrosine phosphorylation of isoform 3 of CD28.
Mediates B-cell proliferation in the absence of co-stimulus as well as IgE production in the presence of IL4.
Involved in immunoglobulin class switching.
Product Notes
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Downloads
Download resources about recombinant antibody development and antibody engineering to boost your research.
See other products for "Clone YMF323.6"
See other products for "CD40LG"
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
MOB-1071z | Mouse Anti-CD40LG Recombinant Antibody (clone 18C1) | ELISA, FC, FuncS, ICC, IF | Mouse IgG1 |
PABW-020 | Human Anti-CD40LG Recombinant Antibody (PABW-020) | Neut | Human IgG1, κ |
HPAB-0880LY | Mouse Anti-CD40LG Recombinant Antibody (HPAB-0880LY) | FC | Mouse IgG1 |
HPAB-0881LY | Mouse Anti-CD40LG Recombinant Antibody (HPAB-0881LY) | FC | Mouse IgG1 |
HPAB-0882LY | Mouse Anti-CD40LG Recombinant Antibody (HPAB-0882LY) | FC | Mouse IgG1 |
Customer Reviews and Q&As
There are currently no Customer reviews or questions for VS-0425-FY79. Click the button above to contact us or submit your feedback about this product.
Popular products with customers
Application: FuncS, IF, Neut, ELISA, FC, IP, ICC
Application: Neut, ELISA, IF, IP, FuncS, FC, ICC
Application: ELISA, FC, IP, FuncS, IF, Neut, ICC
Application: WB, ELISA, FC, IP, FuncS, IF, Neut
Application: Block, Cyt, FuncS, Inhib
Application: ELISA, IHC, FC, WB, IF, IA
Application: ELISA, IHC, FC, IP, IF, Inhib
Application: ELISA, IHC, FC, IP, IF, FuncS
Application: ELISA, FC, FuncS
Application: Inhib, FC, WB
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.